By David Bautz, PhD NASDAQ:ABEO READ THE FULL ABEO RESEARCH REPORT Business Update Zevaskyn™ Approved by FDA On April 29, 2025, Abeona Therapeutics, Inc. (NASDAQ:ABEO) announced that the U.S ...

Abeo had been a strong performer for The Walking Company since it first debuted in 2010. In fact, in 2014, the company told FN it brought in $80 million in sales.